FDA blog aims to chronicle transparency push

FDA said it wanted to be more "transparent," more "open" about its decision-making. Already, the agency has launched a blog to detail its quest for transparency--and solicit input from the public. Enter your comments at will, but remember: no vulgar language allowed. Release

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.